Research progress of SARS-CoV-2 vaccine-related ocular adverse events
Author:
Corresponding Author:

Affiliation:

Clc Number:

Fund Project:

Public Emergency Special Project of Education Department of Shaanxi Provincial Government(No.20JG033)

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Since 2019, severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection has been widespread in the world, causing about 770 million infecting and 6.9 million deaths. Vaccines against SARS-CoV-2 infection have become the main way to prevent the severe SARS-CoV-2. The use of SARS-CoV-2 vaccine has substantial protection against the serious consequences of SARS-CoV-2 infection, but multiple systemic adverse reactions can occur after the use of SARS-CoV-2 vaccine. More and more studies have shown that SARS-CoV-2 vaccine caused lesions of ocular conjunctiva, cornea, sclera, uvea, retina and optic nerve tissue and resulted in damage to visual function. In this paper, the classification and characteristics of SARS-CoV-2 vaccines and related studies on ocular tissue lesions were reviewed, hoping to better understand the ocular adverse reactions of SARS-CoV-2 vaccine and provide some theoretical guidance for the prevention and treatment of ocular tissue damage caused by SARS-COV-2 vaccine.

    Reference
    Related
    Cited by
Get Citation

Zhu Yusheng, Wang Tong, Chen Xiaodong. Research progress of SARS-CoV-2 vaccine-related ocular adverse events. Guoji Yanke Zazhi( Int Eye Sci) 2024;24(6):925-929

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:September 14,2023
  • Revised:April 23,2024
  • Adopted:
  • Online: May 22,2024
  • Published: